Cohort’s final results came in ahead of our forecasts with a record revenue, adjusted operating profit and closing cash performance delivered. The 22% underlying organic revenue growth and 17% underlying operating profit growth was augmented by the MCL and J+S acquisitions, both of which were immediately earnings enhancing. With a closing order book of £134.0m, including a contribution of £38.0m from the acquisitions, we believe Cohort is set for a period of sustained organi
26 Jun 2015
Performance shining through
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Performance shining through
Cohort’s final results came in ahead of our forecasts with a record revenue, adjusted operating profit and closing cash performance delivered. The 22% underlying organic revenue growth and 17% underlying operating profit growth was augmented by the MCL and J+S acquisitions, both of which were immediately earnings enhancing. With a closing order book of £134.0m, including a contribution of £38.0m from the acquisitions, we believe Cohort is set for a period of sustained organi